title: Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders.
abstract: BACKGROUND
  Autism spectrum disorders (ASD) refer to a broader group of neurobiological conditions, pervasive developmental disorders. They are characterised by a symptomatic triad associated with qualitative changes in social interactions, defect in communication abilities, and repetitive and stereotyped interests and activities. ASD is prevalent in 1 to 3 per 1000 people. Despite several arguments for a strong genetic contribution, the molecular basis of a most cases remains unexplained. About 5% of patients with autism have a chromosome abnormality visible with cytogenetic methods. The most frequent are 15q11-q13 duplication, 2q37 and 22q13.3 deletions. Many other chromosomal imbalances have been described. However, most of them remain undetectable using routine karyotype analysis, thus impeding diagnosis and genetic counselling.
  
  
  RESULTS
  29 patients presenting with syndromic ASD were investigated using a DNA microarray constructed from large insert clones spaced at approximately 1 Mb intervals across the genome. Eight clinically relevant rearrangements were identified in 8 (27.5%) patients: six deletions and two duplications. Altered segments ranged in size from 1.4 to 16 Mb (2-19 clones). No recurrent abnormality was identified.
  
  
  CONCLUSIONS
  These results clearly show that array comparative genomic hybridisation should be considered to be an essential aspect of the genetic analysis of patients with syndromic ASD. Moreover, besides their importance for diagnosis and genetic counselling, they may allow the delineation of new contiguous gene syndromes associated with ASD. Finally, the detailed molecular analysis of the rearranged regions may pave the way for the identification of new ASD genes.
authors.affiliation: INSERM U781, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France.
authors.forename: M-L
authors.initials: ML
authors.lastname: Jacquemont
authors.forename: D
authors.initials: D
authors.lastname: Sanlaville
authors.forename: R
authors.initials: R
authors.lastname: Redon
authors.forename: O
authors.initials: O
authors.lastname: Raoul
authors.forename: V
authors.initials: V
authors.lastname: Cormier-Daire
authors.forename: S
authors.initials: S
authors.lastname: Lyonnet
authors.forename: J
authors.initials: J
authors.lastname: Amiel
authors.forename: M
authors.initials: M
authors.lastname: Le Merrer
authors.forename: D
authors.initials: D
authors.lastname: Heron
authors.forename: M-C
authors.initials: MC
authors.lastname: de Blois
authors.forename: M
authors.initials: M
authors.lastname: Prieur
authors.forename: M
authors.initials: M
authors.lastname: Vekemans
authors.forename: N P
authors.initials: NP
authors.lastname: Carter
authors.forename: A
authors.initials: A
authors.lastname: Munnich
authors.forename: L
authors.initials: L
authors.lastname: Colleaux
authors.forename: A
authors.initials: A
authors.lastname: Philippe
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000175:diagnosis* / Q000235:genetics; D002869:Chromosome Aberrations; D002877:Chromosomes, Human; D005260:Female; D005820:Genetic Testing / Q000379:methods; D023281:Genomics / Q000379:methods; D006801:Humans; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D013577:Syndrome